SENS Logo

Senseonics Holdings, Inc. (SENS) 

AMEX
Market Cap
$194.73M
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
710 of 776
Rank in Industry
91 of 100

Largest Insider Buys in Sector

SENS Stock Price History Chart

SENS Stock Performance

About Senseonics Holdings, Inc.

Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It …

Insider Activity of Senseonics Holdings, Inc.

Over the last 12 months, insiders at Senseonics Holdings, Inc. have bought $0 and sold $0 worth of Senseonics Holdings, Inc. stock.

On average, over the past 5 years, insiders at Senseonics Holdings, Inc. have bought $162,000 and sold $15.1M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 300,000 shares for transaction amount of $162,000 was made by ROEDER DOUGLAS A (director) on 2023‑08‑30.

List of Insider Buy and Sell Transactions, Senseonics Holdings, Inc.

2023-09-07Saledirector
30,889
0.0062%
$0.61$18,842-13.28%
2023-08-30Purchasedirector
300,000
0.0619%
$0.54$162,000-0.20%
2022-08-04SaleChief Operating Officer
50,000
0.0103%
$1.97$98,500-47.78%
2022-03-11Sale
63,553
0.014%
$1.65$104,862-28.35%
2022-02-11SalePresident and CEO
464,390
0.1035%
$2.46$1.14M-50.41%
2022-02-11SaleChief Operating Officer
150,197
0.0335%
$2.46$369,485-50.41%
2022-02-11SaleChief Medical Officer
163,870
0.0365%
$2.46$403,120-50.41%
2022-02-11SaleGC & Corp. Development Advisor
143,126
0.0319%
$2.46$352,090-50.41%
2022-02-11SaleVP Global Sales and Marketing
105,760
0.0236%
$2.46$260,170-50.41%
2022-02-11SaleChief Financial Officer
72,873
0.0162%
$2.46$179,268-50.41%
2021-12-06Saledirector
273,076
0.0568%
$2.53$690,882-43.77%
2021-11-16SaleChief Operating Officer
200,000
0.0443%
$3.70$740,000-56.27%
2021-11-16SaleChief Medical Officer
41,996
0.0093%
$3.70$155,385-56.27%
2021-08-25Saledirector
431,494
0.0912%
$3.50$1.51M-45.03%
2021-08-24Saledirector
250,684
0.0561%
$3.65$914,997-43.03%
2021-06-14SaleChief Operating Officer
100,000
0.0143%
$2.45$245,000-27.27%
2021-06-11SaleChief Medical Officer
125,256
0.0289%
$4.00$501,024-27.56%
2021-06-10SalePresident and CEO
761,420
0.1008%
$2.07$1.58M-19.61%
2021-06-10SaleChief Operating Officer
37,732
0.0085%
$3.51$132,439-19.61%
2021-06-09SaleChief Operating Officer
12,268
0.0019%
$2.02$24,781-3.91%

Insider Historical Profitability

34.16%
BARRETT M JAMES
21911183
3.7694%
$0.3420+55.39%
NEW ENTERPRISE ASSOCIATES 10 L P10 percent owner
19476414
3.3506%
$0.34223+55.39%
Delphi Management Partners VIII, L.L.C.10 percent owner
11237221
1.9332%
$0.3410+11.5%
NEW ENTERPRISE ASSOCIATES 9 L P10 percent owner
8949292
1.5396%
$0.3410+11.5%
Goodnow Timothy TPresident and CEO
4737786
0.815%
$0.3414<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
The Vanguard Group$11.96M4.2422.53M+0.7%+$82,700.24<0.0001
BlackRock$6.32M2.2411.91M-2.07%-$133,783.04<0.0001
Masters Capital Management, LLC$3.72M1.327M0%+$00.7
Geode Capital Management$2.98M1.065.61M+3.79%+$108,908.83<0.0001
Charles Schwab$1.64M0.583.09M+2.93%+$46,736.79<0.0001
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.